Compare Marsh & McLennan Companies, Inc. (MRSH) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Summit Therapeutics Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 8.4× Summit Therapeutics Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MRSH | SMMT | |
|---|---|---|
Market Cap | $87.77B | $10.48B |
Sector | Financials | Health |
52-Week High | $211.21 | $29.32 |
52-Week Low | $157.32 | $13.05 |
Enterprise Value | $108.61B | $9.90B |
Dividend Yield | 2.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
